Smithbridge Asset Management Inc Edwards Lifesciences Corp Transaction History

Smithbridge Asset Management Inc

$533 Million
Q1 2025

A detailed history of Smithbridge Asset Management Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Smithbridge Asset Management Inc holds 14,266 shares of EW stock, worth $987,207. This represents 0.19% of its overall portfolio holdings.

Number of Shares

14,266

Previous 13,086 9.02%

Holding current value

$987,207

Previous $863,000 19.7%

% of portfolio

0.19%

Previous 0.15%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 16, 2025	BUY	$67.95 - $76.19 $80,181 - $89,904	1,180 Added 9.02%	14,266 $1.03 Million
Q3 2024 Oct 24, 2024	BUY	$59.7 - $93.78 $131,459 - $206,503	2,202 Added 20.23%	13,086 $863,000
Q2 2024 Jul 19, 2024	SELL	$84.3 - $94.31 $14,078 - $15,749	-167 Reduced 1.51%	10,884 $1.01 Million
Q1 2024 May 03, 2024	BUY	$72.54 - $95.56 $62,239 - $81,990	858 Added 8.42%	11,051 $1.06 Million
Q4 2023 Jan 18, 2024	BUY	$61.71 - $77.76 $25,362 - $31,959	411 Added 4.2%	10,193 $777,000
Q3 2023 Oct 25, 2023	BUY	$69.28 - $93.38 $65,469 - $88,244	945 Added 10.69%	9,782 $678,000
Q2 2023 Jul 20, 2023	BUY	$81.41 - $94.33 $483,331 - $560,037	5,937 Added 204.72%	8,837 $834,000
Q2 2023 Jul 18, 2023	SELL	$81.41 - $94.33 $447,755 - $518,815	-5,500 Reduced 65.48%	2,900 $216,000
Q1 2023 Apr 20, 2023	BUY	$74.26 - $84.51 $408,430 - $464,805	5,500 Added 189.66%	8,400 $695,000
Q4 2022 Mar 01, 2023	SELL	$68.3 - $87.44 $525,910 - $673,288	-7,700 Reduced 72.64%	2,900 $216,000
Q3 2022 Oct 25, 2022	BUY	$82.37 - $107.29 $55,599 - $72,420	675 Added 6.8%	10,600 $876,000
Q1 2022 Apr 25, 2022	BUY	$101.96 - $128.34 $152,940 - $192,510	1,500 Added 17.8%	9,925 $1.17 Million
Q4 2021 Jan 24, 2022	SELL	$106.37 - $130.68 $869,574 - $1.07 Million	-8,175 Closed	0 $0
Q3 2021 Oct 04, 2021	BUY	$102.91 - $122.75 $36,018 - $42,962	350 Added 4.47%	8,175 $925,000
Q2 2021 Jul 23, 2021	BUY	$83.84 - $104.76 $25,152 - $31,428	300 Added 3.99%	7,825 $810,000
Q1 2021 Apr 06, 2021	BUY	$78.68 - $90.67 $184,898 - $213,074	2,350 Added 45.41%	7,525 $629,000
Q4 2020 Jan 21, 2021	BUY	$71.69 - $91.23 $370,995 - $472,115	5,175 New	5,175 $472,000

Others Institutions Holding EW

# of Institutions

1,380

Shares Held

453M

Call Options Held

6.71M

Put Options Held

3.17M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $42.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithbridge Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Smithbridge Asset Management Inc with notifications on news.

Account

Smithbridge Asset Management Inc Edwards Lifesciences Corp Transaction History